Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 606-729-6 | CAS number: 212386-71-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016-03-24 to 2016-10-25
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 489 (In vivo Mammalian Alkaline Comet Assay)
- Version / remarks:
- 09-2014
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 09-2014
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian comet assay
Test material
- Reference substance name:
- (4-ethoxy-2,3-difluorophenyl)boronic acid
- EC Number:
- 606-729-6
- Cas Number:
- 212386-71-5
- Molecular formula:
- C8 H9 B F2 O3
- IUPAC Name:
- (4-ethoxy-2,3-difluorophenyl)boronic acid
- Test material form:
- solid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Raleigh, USA
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 8 weeks
- Weight at study initiation: 213 - 244 g
- Housing: single-housed in high polysulfone cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 1 day
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 23
- Humidity (%): 17 - 47
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From day 1 - 3
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Methocel® K4M Premium
- Details on exposure:
- Vehicle Control: The vehicle control article was 0.25% Methocel® K4M Premium Hydroxypropyl Methylcellulose. The stability of the test item in the vehicle has been demonstrated at least 24 hours at room temperature. Therefore, the test article dose formulations were prepared freshly on each day of dosing. Samples of the dose formulations and the vehicle control that were used for the comet/MN assay were collected for analysis.
Dose Formulation Analysis: Test article dose formulations were accurate since the measured concentrations of the test item were within 15% of their nominal values, which was within the predefined acceptance limits (+/- 15% of nominal). No test article was detected in the vehicle control samples. The quantification of the test item was performed using a HPLC method with UV detection.
Dose Administration: The dose volume for each dose administration was 10 mL/kg. - Duration of treatment / exposure:
- 3 consecutive days
- Frequency of treatment:
- once daily
- Post exposure period:
- no
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Dose / conc.:
- 30 mg/kg bw/day
- Dose / conc.:
- 100 mg/kg bw/day
- Dose / conc.:
- 300 mg/kg bw/day
- Dose / conc.:
- 1 000 mg/kg bw/day
- No. of animals per sex per dose:
- 5 m
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- The positive control group received a single intraperitoneal injection of cyclophosphamide (CP) 24 hours before necropsy. The same group of animals also received a single oral administration of ethyl methanesulfonate (EMS) 4 hours before necropsy. The dose volume for each administration was 10 mL/kg.
Comet Assay: EMS was prepared fresh in dH2O on the day of dosing and administered at a concentration of 300 mg/kg BW.
Micronucleus Assay: CP was prepared fresh in dH2O on the day of dosing and administered at a concentration of 25 mg/kg BW.
Examinations
- Tissues and cell types examined:
- Evaluated samples
Comet assay: liver, glandular stomach and duodenum
Micronucleus assay: bone marrow
Histology: liver, glandular stomach and duodenum - Details of tissue and slide preparation:
- Comet Assay
For each sample, four comet slides (replicates B-E) were prepared and after at least one hour in lysis, liver, duodenum and glandular stomach slide replicates B-E were electrophoresed under alkaline (pH >13) conditions. Prior to electrophoresis, slides were rinsed with 0.4M Tris (pH 7.5) and submerged in alkaline electrophoresis buffer for 20 minutes at 4 - 4.6°C to unwind the DNA. After unwinding, slides were electrophoresed at 4.1 - 5.9°C for 40 minutes at a constant voltage of 0.7V/cm. At the start of electrophoresis, the buffer level was adjusted as necessary to achieve a starting current of approximately 300 mA. After electrophoresis, the electrophoresed slides were neutralized with 0.4M Tris buffer (pH 7.5), dipped in ethanol, air dried and stored at room temperature.
Slides were stained with SYBR Gold™ stain and unless precluded by poor cell density and/or poor sample/slide quality, 150 cells per sample (75 cells per slide, if possible) were scored using the Komet© Image Analysis System. The image analysis version and settings were documented in the raw data. For each sample, 150-182 cells were visually scored for the frequency of ghosts defined as cells with a heavily diffused tail and a non-existent head. Slides were scored without knowledge of the sample treatment group. Any extra replicate comet slides remaining in lysing after comet analysis is complete were not retained. After analysis of the comet slides is complete, the continued quality of the analyzed slides cannot be ensured after >1 month of storage. Therefore, the comet slides were not retained or archived after the report was finalized.
Low Molecular Weight (LMW) DNA Diffusion Assay
To assess for LMW DNA diffusion (%LMW), 1 slide (Replicate A) per comet sample was prepared and lysed for the LMW diffusion assay. After 1-2 hours in lysis, the LMW slides were neutralized with 0.4M Tris buffer (pH 7.5), dipped in ethanol and air dried. Air dried slides were stored at room temperature. After staining slides with SYBR Gold™ stain, 100 cells per sample were scored visually for diffusion and classified using the following categories: I = condensed DNA; II = diffused DNA. Slides were scored without knowledge of the sample treatment group. Since the positive control EMS can be both genotoxic and cytotoxic at the dose it is administered, the %LMW data for the EMS exposure is not considered relevant to the validity of a positive response detected by comet.
Micronucleus Assay
To determine the number of MN-PCEs indicative of clastogenicity or aneugenicity and to assess for the presence of bone marrow suppression indicative of cytotoxicity, at least two MN slides from each animal were analyzed. After staining slides with acridine orange (and unless precluded by low cell density and/or excessive debris), 4000 PCEs per animal were scored for the incidence of micronuclei and 1000 erythrocytes per animal were scored for the percentage of PCEs. Slides were scored without knowledge of the sample treatment group.
Histopathology
Histopathology liver, duodenum and glandular stomach samples from dosed rats and the vehicle control group were analyzed for the presence of cytotoxicity. Tissue samples that had been immersed in fixative were transferred to a different test site for processing and analysis. Tissue samples were processed, embedded in paraffin blocks, sectioned and stained with hematoxylin and eosin. Samples were analyzed by microscopic evaluation for minimal to moderate inflammation and signs of tissue damage or degradation by a board certified veterinary pathologist. - Evaluation criteria:
- Criteria for a Valid Test
-For negative studies, the concurrent positive control must induce a statistically significant (p<0.05) increase in DNA damage as determined by the %Tail or MN-PCEs when compared to the concurrent vehicle control.
-The concurrent negative control must be considered acceptable for addition to the Helix3 historical control database by providing a sufficient dynamic range to detect a positive effect.
Criteria for a Positive Response
The test article may be classified as positive for inducing genotoxicity if the following criteria are met:
a.) a statistically significant increase (indicative of strand breaks) or decrease (indicative of crosslinks) in DNA migration and/or an increase in the incidence of micronuclei is detected at one or more dose concentrations and
b.) a statistically significant dose dependent response is detected in the same endpoint and sample type
Regardless of the parameter (e.g. %Tail vs. OTM), comet data collected by image analysis is measured on a continuous scale with an infinite and continuously expanding range of historical values. Therefore, only concurrent control groups within the same experiment were compared to test article dose groups for the determination of a positive response.
A test article may be classified as equivocal for inducing genotoxicity if either criteria (a) or (b) are met, but not both. If an increase in cytotoxicity is detected in the same tissue and dose concentration(s) at which DNA damage is significantly affected, cytotoxicity may be considered a confounding factor in the determination of genotoxicity and a repeat test with the same and/or lower doses may be recommended to verify the presence of genotoxicity in the absence of cytotoxicity. If neither criteria (a) nor (b) are met and direct or indirect evidence of target organ exposure can be demonstrated, the test article may be classified as negative for inducing genotoxicity. - Statistics:
- Standard statistical methods incl. Analyse-It software were used
Results and discussion
Test resultsopen allclose all
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Remarks:
- Comet assay: Negative for inducing genotoxicity in the liver and glandular stomach. The duodenum was assessed as an inappropriate tissue to test with this experimental design.
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Sex:
- male
- Genotoxicity:
- ambiguous
- Remarks:
- Micronucleus assay: Equivocal in the bone marrow of treated animals when dosed up to the toxic dose.
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Comet/MN Assay
Minor clinical observations (e.g. lethargy, irregular breathing, partially closed eyelids, porphyrin staining, tremors and spasms) were noted in two animals in the 1000 mg/kg dose group. During necropsy, bloating and distension in the stomach and duodenum was noted in one these two rats. Compared to the vehicle control dose group, there was a 25, 5, 42 and 164% decrease in average body weight gain in the 30, 100, 300 and 1000 mg/kg test article dose groups, respectively.
The liver (%Tail only), duodenum, glandular stomach and bone marrow %MN-PCE data were normally distributed. The liver %LMW and bone marrow %PCE data were not normally distributed. The toxic dose was determined to be 1000 mg/kg based on liver mucosal degeneration in histopathology samples and the 164% decrease in average body weight gain. To determine the presence of a linear dose response in the absence of the toxic dose group, additional trend tests were performed excluding the 1000 mg/kg dose group for all tissues.
Liver Comet
Based on statistical analysis using pairwise comparisons, neither a significant increase nor decrease in DNA migration or %LMW was detected in the liver at any dose concentration evaluated. Based on trend tests, a dose-dependent increase was detected in DNA migration, but no response (increase or decrease) was detected in %LMW. When the toxic dose group was excluded from statistical analysis, no dose-dependent response was detected in DNA migration or %LMW. EMS induced a significant increase in DNA migration and %LMW.
Duodenum Comet
Based on statistical analysis using pairwise comparisons, a significant decrease in DNA migration was detected in the duodenum at 30 and 1000 mg/kg dose concentrations. A significant decrease in %LMW was detected at 100 and 1000 mg/kg dose concentrations. Based on trend tests, no dose-dependent response was detected in either endpoint with or without the toxic dose group included in analysis. EMS did not induce a significant increase in DNA migration compared to the vehicle control. This was due to a higher than average background level of DNA migration in the vehicle control group. Since higher background levels of DNA migration in the duodenum have been associated with multiple administrations of viscous vehicles such as Methocel K4M Premium, the duodenum was an inappropriate tissue for this study design resulting in an invalid test for this tissue.
Glandular Stomach Comet
Based on statistical analysis using pairwise comparisons, no response in DNA migration or %LMW was detected in the glandular stomach at any dose concentration evaluated. Based on trend tests, no dose-dependent response was detected in either endpoint with or without the toxic dose group included in analysis. EMS induced a significant increase in DNA migration but neither an increase nor decrease in %LMW.
Bone Marrow MN
Based on statistical analysis using pairwise comparisons and trend tests, a significant and dose-dependent increase in MN-PCEs was detected at 30 and 1000 mg/kg dose concentrations. A significant dose-dependent decrease in %PCEs was not detected at any dose concentration. When the toxic dose group was excluded from statistical analysis, no dose-dependent response was detected in either endpoint. CP induced a significant increase in MN-PCEs without a decrease in %PCEs.
Histopathology Evaluation
Degeneration of liver hepatocytes was present in two males in the 1000 mg/kg dose group and considered related to oral administration of the test item. Degeneration of hepatocytes consisted of a spectrum of changes including homogenization of cytoplasm, absence of cytoplasmic detail, nuclear fragmentation, and retention of cytoplasmic membranes. A single gross finding was reported in one of these two rats and included distension and bloating of the stomach and duodenum. Examination of the stomach and duodenum did not reveal any abnormalities and no microscopic correlates were present for the gross findings recorded.
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions of this study, the test item was negative for inducing genotoxicity in the liver and glandular stomach and equivocal in the bone marrow of treated animals when dosed up to the toxic dose. Since the duodenum was an inappropriate tissue to test with this experimental design and a valid test was achieved in the glandular stomach as the site of contact, a repeat test in the duodenum is not recommended.
- Executive summary:
Objective
This study was intended to evaluate the potential of the test item to induce genotoxicity in the liver, duodenum, glandular stomach and bone marrow of male Sprague Dawley rats following oral administration. Among the various mechanistic-based techniques for evaluating the genotoxic activity of a test article, the comet assay can detect DNA damage (strand breaks, alkali-labile sites, cross-linking, adduct formation) in individual cells from any target organ and regardless of mitotic activity. Combined with or supplemental to the in vivo micronucleus (MN) assay which can detect clastogens and aneugens in the bone marrow and peripheral blood, this study provided the best method for determining the genotoxicity of the test article.
Study design
Groups of 5 male Sprague Dawley rats were dosed orally once daily via gavage with 0, 30, 100, 300 or 1000 mg/kg over 3 consecutive days. The sample time was 4 hours after last dosing and the evaluated samples in the comet assay were liver, glandular stomach, duodenum and in the micronucleus assay the bone marrow. A histopathological examination in liver, glandular stomach and duodenum was performed.
Results
In the comet assay, there was no response in the liver or glandular stomach. In the MN assay, a significant and dose dependent increase in MN-PCEs was induced in the bone marrow at 1000 mg/kg. However, since liver toxicity and a significant decrease in body weight gain was also detected at this dose level, the increase in micronuclei may be due to toxicity. With the exclusion of the toxic dose from statistical analysis, there was no dose-dependent increase in MN-PCEs. A significant increase in MN-PCEs at a dose level of 30 mg/kg was within the historical control range for the vehicle control and is most likely a statistical artefact.
Conclusion
Under the experimental conditions of this study, the test item was negative for inducing genotoxicity in the liver and glandular stomach and equivocal in the bone marrow of treated animals when dosed up to the toxic dose. Since the duodenum was an inappropriate tissue to test with this experimental design and a valid test was achieved in the glandular stomach as the site of contact, a repeat test in the duodenum is not recommended.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.